Related Experiment Video
Updated: Feb 4, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Radium 223 in castration resistant prostate cancer.]
Ana Loizaga-Iriarte1, Isabel Camargo Ibargarai2, Nerea Senarriaga-Ruiz de la Illa2
1Hospital Universitario Basurto. Bilbao. España.CIBERONC.España.
Radium 223 therapy, an alpha emitter, significantly improves survival for castration-resistant prostate cancer patients with bone metastases. This bone-targeted treatment also reduces skeletal events and has manageable side effects.
Area of Science:
- Oncology
- Radiopharmaceutical Therapy
- Prostate Cancer Research
Background:
- Castration-resistant prostate cancer (CRPC) with bone metastases presents significant challenges.
- Bone metastases in CRPC lead to pain, skeletal events, and reduced survival.
- Existing treatments often have limited efficacy or significant toxicity.
Purpose of the Study:
- To analyze evidence for Radium 223 dichloride (Ra-223) in CRPC patients with bone metastases.
- To evaluate the efficacy and safety of Ra-223 based on pivotal trials and real-world data.
- To explore ongoing research involving Ra-223 in combination therapies.
Main Methods:
- Review of the pivotal ALSYMPCA study for Ra-223 drug approval.
- Analysis of post-approval data and real-world evidence for Ra-223.
- Literature search for ongoing clinical trials of Ra-223 in CRPC.
Main Results:
- The ALSYMPCA study demonstrated a significant overall survival benefit for Ra-223 (3.6 months median increase).
- Ra-223 reduced the risk of death by 30% and improved survival rates at 36 months (46%).
- Ra-223 positively impacted symptomatic skeletal events and bone markers, confirming efficacy in bone metastases.
Conclusions:
- Radium 223 is the first bone-targeted therapy to significantly improve overall survival in CRPC.
- Ra-223 prolongs time to first skeletal event and prostate-specific antigen (PSA) increase.
- Ra-223 exhibits a manageable safety profile, with fewer adverse effects than placebo in the ALSYMPCA trial.
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...

